Название продукции:6-Hydroxy-3,4-dihydronaphthalen-1(2H)-one
IUPAC Name:6-hydroxy-1,2,3,4-tetrahydronaphthalen-1-one
- CAS:3470-50-6
- Молекулярная формула:C10H10O2
- Чистота:95%
- Номер в каталоге:CM141297
- Молекулярная масса:162.19
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:3470-50-6
- Молекулярная формула:C10H10O2
- Точка плавления:-
- Smiles-код:O=C1CCCC2=C1C=CC(O)=C2
- Плотность:
- Номер в каталоге:CM141297
- Молекулярная масса:162.19
- Точка кипения:358°C at 760 mmHg
- Номер Mdl:MFCD00156670
- Хранение:Store at 2-8°C.
Category Infos
- Naphthalenes
- Naphthalene is a hydrocarbon produced by the distillation of coal tar and is an aromatic white crystalline substance. Naphthalene is the most abundant component in coal tar. It is used as an insect repellant and insect fumigant. The compound is used in the manufacture of celluloid, dyes, hydrogenated naphthalenes, oil fumes, smokeless powders and synthetic resins.
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Vepdegestrant
- Arvinas and Pfizer updated clinical data from a Phase 1b combination cohort evaluating vepdegestrant in combination with palbociclib. These data show that vepdegestrant plus palbociclib continue to demonstrate encouraging clinical activity in heavily pre-treated patients with a median of four lines of prior therapy with locally advanced or metastatic ER positive/human epidermal growth factor 2 – HER2 – negative breast cancer. Vepdegestrant is an investigational PROTAC ER degrader designed to harness the body’s natural protein disposal system to specifically target and degrade the estrogen receptor.